Unilor tablet: Each film coated tablet contains Desloratadine INN 5 mg. Unilor syrup: Each 5 ml contains Desloratadine INN 2.5mg
Desloratadine is a long-acting tricyclic histamine antagonist with selective H1-receptor antagonist activity. It is a non-sedating antihistamine. Desloratadine has effects on the chronic inflammatory response to allergens.
Allergic rhinitis: Desloratadine is indicated for the relief of nasal and non-nasal symptoms of allergic rhinitis (seasonal and perennial). Chronic idiopathic urticaria: Desloratadine is indicated for the symptomatic relief of pruritus, reduction in the number of hives and size of hives, in patients with chronic idiopathic urticaria.
DOSAGE AND ADMINISTRATION
Unilor Syrup: Child 2-5 years of Age: 1/2 teaspoonful once daily.
Child 6-11 years of Age:1 teaspoonful once daily Adults &> years of Age: 2 teaspoonful once daily Unilor Tablet: Adults and children 12 years of age and over: 1 Tablet daily.
USE IN PREGNANCY AND LACTATION
Pregnancy: There are no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, Desloratadine should be used in pregnancy only if clearly needed. Lactation: Desloratadine passes into breast milk. Therefore, a decision should be made whether to discontinue nursing or to discontinue Desloratadine, taking into account the importance of the drug to the mother.
Desloratadine is generally well tolerated. However, dry mouth, fatigue, somnolence and myalgia are commonly reported side-effects. Less common side-effects may include dizziness, headache and nausea. Rarely rash, pruritus and urticaria may occur.
Desloratadine is contraindicated in patients who are hypersensitive to this medication or to any of its ingredients or to Loratadine.
Alcohol enhances the sedative effect of Desloratadine. Erythromycin, Ketoconazole, Cimetidine & Amprenavir may increase plasma concentration of Loratadine.
SPECIAL PRECAUTIONS FOR USE
Antihistamine should be used with caution in prostatic hypertrophy, urinary retention, glaucoma, and pyloroduodenal obstruction. It should be used with caution in hepatic disease and dose reduction may be necessary in the renal impairment. Caution may be required in epilepsy and porphyria. Children and the elderly are more susceptible to side effects.
No clinically relevant adverse effects have been reported in case of over dosage. However, in the event of overdosage, symptomatic and supportive treatment is recommended.
Store in a cool (Below 30⁰ C. Temp.), dry place and protect from light. Keep all medicines out of the reach of children.
Unilor tablet: Each box containing 50’s tablets in blister strips. Unilor syrup: Each bottle containing 60 ml.